![]()
Biotech Industry
The latest biotech headlines from MarketWatch.
Illumina shareholders vote to elect one of Carl Icahn’s candidates to its board after proxy fight
Illumina Inc. ILMN shareholders voted Thursday to elect one of activist investor Carl Icahn’s nominees to its board, and voted against the re-elect...
Sarepta says FDA is working toward accelerated approval of its latest treatment for Duchenne muscular dystrophy
Sarepta Therapeutics Inc. SRPT said Wednesday that the U.S. Food and Drug Administration has indicated after talks with the company that it’s worki...
Most Popular
More Biotech Headlines
Achieve Life Sciences says confirmatory late-stage trial of its treatment for quitting smoking achieved positive results
Achieve Life Sciences Inc. ACHV said Tuesday a second confirmatory late-stage trial of its cytisinicline for quitting smoking and nicotine dependence achieved positive results, showing a statistically significant benefit c...
House-flipping influencer and life coach hit with hefty fines in bogus $400 million training program and 5 hottest metros are in the south
Monday's top personal finance stories.
Intercept Pharmaceuticals stock tumbles toward 11-month low after disappointing FDA committee vote
Shares of Intercept Pharmaceuticals Inc. ICPT tumbled 15.2% toward an 11-month low in premarket trading Monday, after the biopharmaceutical company said a U.S. Food and Drug Administration committee voted to “defer approva...
Ironwood Pharmaceuticals to acquire Swiss biotech VectivBio in deal valued at about $1 billion
Ironwood Pharmaceuticals Inc. IRWD said Monday it has agreed to acquire Swiss biotech VectivBio Holding AG VECT for $17 a share in cash, or a total of about $1 billion, net of VectivBio’s cash and debt. The price is equal ...
Krystal Biotech stock rises after FDA approves treatment for rare skin disease
Krystal Biotech Inc. KRYS shares rose Friday after the biotech drug company received Food and Drug Administration approval of a rare skin disease treatment. Krystal shares rose as much as 8% to an intraday high of $94.61 a...
Why is Elizabeth Holmes going to prison? A recap of how the Theranos founder got here
Holmes, who was convicted of defrauding Theranos investors, is set to begin her 11-year prison sentence on May 30.
Corrected Here’s the big thing holding up the stock market, says Bank of America
Investors want to see the economy land softly softly, and that is the main thing that will keep assets resilient, say BofA managers.
Horizon shares sink on report that FTC will sue to block takeover by Amgen
Shares of Horizon Therapeutics Inc. plunged 15% in extended trading Monday after Bloomberg News reported the FTC is expected to file a lawsuit to block Amgen Inc.'s $27.8 billion acquisition of Horizon.
Athenex files for Chapter 11 seeking buyer for its drug candidates
Athenex Inc. ATNX, a biotech that specializes in cancer treatments, said late Sunday it has filed for Chapter 11 bankruptcy with an agreement with lenders to pursue an expedited sale of its assets. The company is expecting...
Sarepta stock soars 30% premarket after FDA panel backs accelerated approval for Duchenne muscular dystrophy therapy
Sarepta Therapeutics Inc.’s stock SRPT soared 30% premarket Monday, after a U.S. Food and Drug Administration panel voted 8-6 in favor of accelerated approval for the company’s latest gene therapy for Duchenne muscular dy...
Sarepta Therapeutics stock halted premarket ahead of FDA panel meeting on new Duchenne muscular dystrophy treatment
Sarepta Therapeutics Inc. stock SRPT was halted premarket Friday, ahead of a meeting of a Food and Drug Administration advisory panel to discuss the company’s SRP-9001 gene therapy for the rare genetic disorder Duchenne mu...
ImmunityBio stock loses more than half its value after disclosing FDA can’t approve the BLA for its cancer treatment in its present form
Shares of ImmunityBio Inc. IBRX plummeted 53.7% toward a record one-day selloff in premarket trading Thursday, after the immunotherapy company disclosed it received a “complete response letter” from the U.S. Food and Drug ...
As COVID public health emergency ends, ‘whack-a-mole’ virus won’t be easy to track
The U.S. COVID-19 public health emergency comes to an end on Thursday, but the fight against COVID goes on.
Syneos Health to be acquired by private investment consortium for about $7.1 billion in cash
Syneos Health Inc.’s stock SYNH soared 9% in premarket trade Wednesday, after the biopharma services company said it has agreed to be acquired by a private investment consortium for about $7.1 billion in cash. Under the te...
Novavax’s stock soars after positive COVID and flu trial data and news of plan to lay off 25% of workforce
The news helped ease fears raised by the company's "going-concern" language earlier this year.
CTI BioPharma shares soar 83% after Swedish Orphan Biovitrum announces $1.7 billion deal for the biotech
Swedish Orphan Biovitrum AB, or Sobi, SE:SOBI on Wednesday announced that it has entered into an agreement to acquire U.S.-based CTI BioPharma Corp. CTIC in a deal valued at $1.7 billion. Shares of CTI soared 83% in premar...
TScan Therapeutics stock soars after Amgen collaboration on Crohn’s disease treatment that could bring in more than $500 million
Shares of TScan Therapeutics Inc. TCRX powered up 43.1% in premarket trading Tuesday, after the biopharmaceutical company announced a collaboration with Amgen Inc. AMGN to treat Crohn’s disease that could be worth more tha...
Longeveron stock up 15.5% premarket after positive results in trial of treatment for rare congenital heart defect in infants
Longeveron Inc.’s stock LGVN rocketed 15.5% in premarket trade Tuesday, after the biotech said its Lomecel-B for the treatment of a congenital heart defect in infants (Hypoplastic Left Heart Syndrome) achieved 100% surviva...
Salarius Pharmaceuticals stock soars premarket after FDA lifts partial clinical hold on trial of treatment for rare form of cancer that starts in childhood
Salarius Pharmaceuticals Inc.’s stock SLRX soared 33% in premarket trade Tuesday after the company said the U.S. Food and Drug Administration has lifted a partial clinical hold on a trial of a treatment for Ewing sarcoma,...
Trevena stock soars toward 5-fold gain in very active trading, after pain treatment gets approved in China
Shares of Trevena Inc. TRVN exploded more than five-fold higher — up 420.6% — on very active trading Monday, after the Pennsylvania-based biopharmaceutical company said its China-based partner Jiangsu Nhwa received formal ...
